华润医药旗下子公司启动潜在出售天麦生物科技发展5.88%股权

美股速递
Yesterday

华润医药集团有限公司旗下子公司已启动一项潜在交易,计划处置其持有的天麦生物科技发展有限公司5.88%的股权。此举标志着华润医药在优化资产组合方面迈出重要一步,市场关注此次股权处置对双方未来战略布局的影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10